97 related articles for article (PubMed ID: 21273616)
1. Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer.
Korkeila E; Jaakkola PM; Syrjänen K; Pyrhönen S; Sundström J
Anticancer Res; 2011 Jan; 31(1):311-5. PubMed ID: 21273616
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
Havelund BM; Sørensen FB; Lindebjerg J; Spindler KL; Jakobsen A
Anticancer Res; 2011 May; 31(5):1559-65. PubMed ID: 21617210
[TBL] [Abstract][Full Text] [Related]
3. Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer.
Korkeila EA; Syrjänen K; Bendardaf R; Laulajainen M; Carpén O; Pyrhönen S; Sundström J
Hum Pathol; 2011 Mar; 42(3):384-92. PubMed ID: 21190723
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
Korkeila EA; Sundström J; Pyrhönen S; Syrjänen K
Anticancer Res; 2011 Dec; 31(12):4529-35. PubMed ID: 22199327
[TBL] [Abstract][Full Text] [Related]
5. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
Grillo-Ruggieri F; Mantello G; Berardi R; Cardinali M; Fenu F; Iovini G; Montisci M; Fabbietti L; Marmorale C; Guerrieri M; Saba V; Bearzi I; Mattioli R; Bonsignori M; Cascinu S
Dis Colon Rectum; 2007 Oct; 50(10):1594-603. PubMed ID: 17846841
[TBL] [Abstract][Full Text] [Related]
6. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
7. [Morphologic changes in cancer of the rectum under the influence of preoperative radiotherapy].
Smirnov IM; Simbirtseva LP; Sneskho LI
Vopr Onkol; 1973; 19(6):49-56. PubMed ID: 4360328
[No Abstract] [Full Text] [Related]
8. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
[TBL] [Abstract][Full Text] [Related]
9. Combined modality therapy in low risk (T2N0) rectal cancer.
Coco C; Magistrelli P; Netri G; Cogliandolo S; Carbone L; Morganti AG; Ziccarelli L; Valentini V
Rays; 1995; 20(2):156-64. PubMed ID: 7480864
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
13. Study of molecular prognostic factors Bcl-2 and EGFR in rectal mucinous carcinomas.
Afrem G; Mogoantă SS; Secureanu FA; Olaru A; Neamţu C; Totolici BD; Ionilă M; Crăiţoiu S
Rom J Morphol Embryol; 2012; 53(2):277-85. PubMed ID: 22732796
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
[TBL] [Abstract][Full Text] [Related]
15. Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer.
Havelund BM; Sørensen FB; Pløen J; Lindebjerg J; Spindler KL; Jakobsen A
APMIS; 2013 Feb; 121(2):127-38. PubMed ID: 23030583
[TBL] [Abstract][Full Text] [Related]
16. GLUT-1 expression and response to chemoradiotherapy in rectal cancer.
Brophy S; Sheehan KM; McNamara DA; Deasy J; Bouchier-Hayes DJ; Kay EW
Int J Cancer; 2009 Dec; 125(12):2778-82. PubMed ID: 19569052
[TBL] [Abstract][Full Text] [Related]
17. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
18. L-type amino-acid transporter 1 expression predicts the response to preoperative hyperthermo-chemoradiotherapy for advanced rectal cancer.
Ebara T; Kaira K; Saito J; Shioya M; Asao T; Takahashi T; Sakurai H; Kanai Y; Kuwano H; Nakano T
Anticancer Res; 2010 Oct; 30(10):4223-7. PubMed ID: 21036745
[TBL] [Abstract][Full Text] [Related]
19. VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy.
Zlobec I; Steele R; Compton CC
Cancer; 2005 Dec; 104(11):2517-21. PubMed ID: 16222693
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
